New pill targets advanced breast cancer in First-Ever human trial
Disease control
Recruiting now
This is the first study in people testing a new oral drug called BBI-940 for advanced or metastatic breast cancer. The main goal is to find a safe and tolerable dose, either alone or combined with another cancer drug. Researchers will enroll about 96 adults whose cancer has progr…
Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC